|Articles|February 4, 2016
LabConnect Builds New Biorepository Facility
The facility features space for ambient, refrigerated, cold and ultra-low temperature storage as well as liquid nitrogen vapor phase storage with storage capacity for more than 8 million samples.
Advertisement
LabConnect, a global central laboratory provider, has built a new biorepository facility to expand services and better meet the evolving needs of the industry. The Johnson City, Tenn.-based facility features space for ambient, refrigerated, cold (-20C) and ultra-low temperature (-70C to -80C) storage as well as liquid nitrogen vapor phase storage (-190C), with storage capacity for more than 8 million samples.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5